According to the firm, the latest acquisition gives Tempus a $300 profitable germline testing lab. Plus, it’ll strengthen Tempus AI product offerings and help it expand into new territory.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback